NCT07033676View on ClinicalTrials.gov

Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease

Enrolling by invitationOBSERVATIONAL

Enrollment

46

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

HypertensionHeart Disease

Trial Locations (1)

Unknown

the University of Hongkong-Shenzhen Hospital, Shenzhen

All Listed Sponsors

lead

The University of Hong Kong-Shenzhen Hospital

OTHER